<ѻý>Study Suggests Path Connecting Periodontal Disease With Rheumatoid Arthritisѻý> Exposing immune system to citrullinated bacterial proteins seen as trigger Feb 22, 2023
<ѻý>Taltz Safety, Efficacy Stay Robust in Spondyloarthritis at 3 Yearsѻý> Benefits appear durable for patients in a long-term extension Feb 21, 2023
<ѻý>Wearable Sensors Show Promise for Remote OA Assessmentѻý> Provide good data and most patients can manage them, small trial indicates Feb 06, 2023
<ѻý>Mileage Varies for Different Hip Surgery Approachesѻý> No single "best" in meta-analysis, though a clear loser emerges Jan 31, 2023
<ѻý>Blood Test Bests Standard OA Prognostic Models in Early Studyѻý> Multi-marker panel does a better job of predicting who will show rapid progression Jan 25, 2023
<ѻý>In Knee OA, Exercise Is Helpful ... But Maybe More in Mind Than Bodyѻý> Trial shows little extra benefit from intensive program Jan 23, 2023
<ѻý>JAK Inhibitor Promising for Polymyalgia Rheumaticaѻý> Oral drug seen as safer than chronic, high-dose steroids Jan 09, 2023
<ѻý>Why Doesn't Exercise Help Everyone With Knee OA?ѻý> Actually, the better question is why can't everyone do the recommended exercises Jan 04, 2023
<ѻý>Metformin Protective Against Joint Replacement in Type 2 Diabetesѻý> Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
<ѻý>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One!ѻý> Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<ѻý>Xeljanz Cancer Risks Detailedѻý> New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<ѻý>Common Treatments for Knee Osteoarthritis May Be Harmfulѻý> Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
<ѻý>Bone Drug Reverses Damage in Hand Osteoarthritisѻý> Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
<ѻý>Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritisѻý> Novel approach to normalizing immune activity Nov 14, 2022
<ѻý>Another Adalimumab Biosimilar Seems Set for Interchangeabilityѻý> Trial data pave way for FDA approval Nov 14, 2022
<ѻý>Want a Few Weeks of Knee Pain Relief? Try Thisѻý> Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
<ѻý>Chronic Pain: Opioids No Longer Treatment of Choiceѻý> Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
<ѻý>New ACR/EULAR Guideline Expands RA Remission Definitionѻý> Axial spondyloarthritis guidance also gets an update Oct 25, 2022
<ѻý>Does Rheumatoid Arthritis Get Its Start in the Gut?ѻý> Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
<ѻý>Is PMR the Next Indication for Tocilizumab?ѻý> Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
<ѻý>Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era?ѻý> Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
<ѻý>Pirfenidone Shows Hints of Benefit for RA-Related Lung Diseaseѻý> But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
<ѻý>Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritisѻý> But is Russian backing a problem for U.S. approval? Aug 24, 2022
<ѻý>More Bad Safety News for Xeljanzѻý> Yet another risk confirmed in postmarketing study Aug 04, 2022
<ѻý>Lubricant Shots for Knee OA: No, They Really Don't Helpѻý> Meta-analysis of hyaluronic acid trials throws serious shade on common practice Jul 06, 2022
<ѻý>Novel Anti-TNF Shines in Rheumatoid Arthritis Trialѻý> Trivalent "nanobody" biologic engineered to accumulate in inflamed tissue Jun 24, 2022
<ѻý>Guideline: Timing Is Everything for RA and Lupus Patients Needing Joint Replacementѻý> New advice on which antirheumatic meds to continue and which to stop before surgery Jun 21, 2022
<ѻý>Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritisѻý> Phase II results suggest drug could outperform existing agents Jun 03, 2022
<ѻý>Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritisѻý> Vindication for clinicians who ignored official recommendations Jun 03, 2022
<ѻý>Air Pollution and Illness: It's Not Just the Lungs and Heart Anymoreѻý> Expanding range of conditions caused or aggravated by fine particulates Jun 01, 2022
<ѻý>Is Alzheimer's Risk Lower With TNF Inhibitors?ѻý> For arthritis patients with cardiovascular disease, the answer may be yes Apr 08, 2022
<ѻý>'It's an Alien Knee in There': Mixed Feelings After Joint Replacementѻý> Study highlights common, but rarely discussed, problem Mar 28, 2022
<ѻý>Glaucoma: The Newest Autoimmune Disease?ѻý> Researchers argue for a "paradigm shift" Mar 21, 2022
<ѻý>Reassurance on Steroid Shots for Knee OAѻý> Study counters fears that injections worsen underlying pathology Mar 17, 2022
<ѻý>Ankylosing Spondylitis: Another Step Toward Individualized Therapyѻý> Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
<ѻý>Hopes Dashed for Novel Osteoarthritis Treatmentѻý> Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
<ѻý>Two Years On, Tremfya Still Shines in Psoriatic Arthritisѻý> Efficacy increases in long-term extension data Feb 10, 2022
<ѻý>Mystery: Why Would Hand OA Be Less Severe in Black People?ѻý> Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022